40 studies found for:    Open Studies | "Candidiasis"
Show Display Options
Rank Status Study
21 Unknown  Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week
Condition: Pulmonary Candidiasis
Intervention: Drug: fluconazole
22 Unknown  Anidulafungin Pharmacokinetics in Intensive Care Unit Patients
Conditions: Invasive Candidiasis;   Candidemia
23 Recruiting Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis
Conditions: Bacterial Vaginosis;   Vulvovaginal Candidiasis;   Trichomoniasis
Intervention: Other: NAAT testing
24 Recruiting Immunological Interaction Between the Host and Candida Albicans Biofilm
Condition: Candidiasis
25 Unknown  Pre-hospital Risk Factors for Invasive Fungal Infection
Conditions: Acute Myeloid Leukemia;   Aspergillosis;   Candidiasis;   Mycoses
26 Recruiting Study To Assess The Safety, Pharmacokinetics, And Evaluate The Response To Anidulafungin When Treating Children With Invasive Candidiasis
Condition: Candidemia
Interventions: Drug: anidulafungin;   Drug: fluconazole
27 Recruiting Variability of Fluconazole Concentration in Critically Ill Patients
Condition: Invasive Candidiasis
28 Recruiting BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia
Condition: Invasive Candidiasis
29 Recruiting Pharmacokinetics of Micafungin in Patients of Intensive Care Units
Condition: Invasive Candidiasis
Intervention: Other: micafungin
30 Recruiting Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation
Condition: Invasive Candidiasis
Intervention: Drug: Micafungin
31 Recruiting Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Conditions: Anticytokine Autoantibody-Associated Diseases;   Disseminated Non-Tuberculous Mycobacteria;   Chronic Mucocutaneous Candidiasis;   Pulmonary Alveolar Proteinosis (PAP)
Intervention: Drug: Rituximab/Rituxan
32 Recruiting A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers
Conditions: Superficial Mycoses;   Dermatomycoses;   Candidiasis;   Histoplasmosis
Interventions: Drug: Lozanoc 50mg;   Drug: Sporanox 100mg
33 Unknown  A Pilot Study for the Use of Biomarkers and Early Treatment of Invasive Candidiasis in Intensive Care Unit (ICU) Patients
Condition: Candidemia
Intervention: Drug: Anidulafungin
34 Unknown  Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast Vaginitis
Condition: Vaginal Candidiasis
Interventions: Drug: Probiotics (Natural product);   Drug: Probiotics (L. rhamnosus GR-1 and L. reuteri RC-14)
35 Unknown  Biliary Candidiasis - Optimization of Diagnostics and Therapy
Conditions: Secondary Cholangitis;   Bile Duct Strictures of Unknown Origin
Intervention: Procedure: ERCP
36 Not yet recruiting Bio-assay Development and Implementation for Fungal Infection Detection
Condition: Candidemia
Intervention: Other: Candidemia
37 Recruiting Serial Therapeutic and Antifungal Monitoring Protocol
Condition: Candidemia
38 Unknown  Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia
Condition: Candidemia
Intervention: Drug: Interferon-gamma, Recombinant
39 Unknown  Risk Factor and Outcome of Candidemia
Condition: Candidemia
40 Unknown  The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of Fungemia
Condition: Candidemia Prognostic Factor and Mycobiological Analysis.

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years